Best China Stocks To Watch For 2019

When you look at Tuesday’s market action, it’s clear what matters most, Jim Cramer told his Mad Money viewers. No, it’s not earnings, or the Federal Reserve. It’s China. Last night’s calming words from Chinese President Xi Jinping took the market right back to 2017, before the words “tariff” and “trade war” loomed in the investing conversation.

Xi’s comments on a more open China sent shares of Boeing (BA) and Caterpillar (CAT) up 3.8% and 3.5% while Apple (AAPL) , an Action Alerts PLUS holding, rose by 1.8%.

Beyond China, the markets also rewarded Facebook (FB) with a gain of 4.5% as CEO Mark Zuckerberg answered questions before Congress in a coherent and respectful manner. Facebook allowed the other FANG stocks to rally, with Amazon (AMZN) and Netflix (NFLX) both ending the day higher, along with most of Cramer’s “cloud kings” like Workday (WDAY) , up 2.6%, and Red Hat (RHT) jumping 3.5%.

Best China Stocks To Watch For 2019: Hanwha Q CELLS Co., Ltd. (HQCL)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million.
    Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million.
    Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million.
    Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share.
    SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million.
    Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million.
    Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million.
    VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.

     

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Agilent Technologies, Inc. (NYSE: A) to post quarterly earnings at $0.64 per share on revenue of $1.21 billion after the closing bell. Agilent shares rose 0.86 percent to close at $69.45 on Friday.
    Analysts expect Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) to report quarterly earnings at $0.14 per share on revenue of $438.40 million before the opening bell. Hanwha Q CELLS shares fell 0.29 percent to close at $6.92 on Friday.
    NiSource Inc. (NYSE: NI) disclosed a 24.96 million share common stock offering via selling holders. NiSource shares rose 0.08 percent to close at $24.93 on Friday.
    Analysts are expecting Vipshop Holdings Limited (NYSE: VIPS) to have earned $0.18 per share on revenue of $3.10 billion in the latest quarter. Vipshop will release earnings after the markets close. Vipshop shares rose 0.20 percent to $15.14 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Rich Smith]

    Shares of Hanwha Q Cells Co (NASDAQ:HQCL) are down more than 4% so far this year — and that’s the good news. Canadian Solaris off 20% while JinkoSolar Holdingis down a whopping 43%. The cost of Chinese solar modules, which make up one-third the cost of a deployed solar power system, are expected to decline 35% this year, then fall another 10% to 15% next year, according to Bloomberg.

Best China Stocks To Watch For 2019: Houghton Mifflin Harcourt Company(HMHC)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Houghton Mifflin Harcourt Co (NASDAQ:HMHC) have been assigned an average rating of “Hold” from the nine research firms that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $9.92.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Houghton Mifflin Harcourt (HMHC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Houghton Mifflin Harcourt (HMHC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best China Stocks To Watch For 2019: iShares Nasdaq Biotechnology Index Fund(IBB)

Advisors’ Opinion:

  • [By Jim Crumly]

    Biotech shares soared on good news from clinical trials; theiShares NASDAQ Biotechnology ETF (NASDAQ:IBB) gained 3.8%.The tech sector also had a big day, with theTechnology Select Sector SPDR ETF (NYSEMKT:XLK) jumping 1.2%.

  • [By Benzinga News Desk]

    After eking out a modest gain in the week ended April 27, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) pulled back this week amid some not-so-encouraging earnings reports and negative regulatory decisions: Link

  • [By Jim Crumly]

    Biotech stocks had a big day, with theiShares NASDAQ Biotechnology ETF (NASDAQ:IBB) jumping 2.8%. The broad technology sector slipped, and theTechnology Select Sector SPDR ETF (NYSEMKT:XLK)lost 0.1%.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)– which is an exchange-traded fund that holds nearly 200 biotech stocks — has drastically underperformed the S&P 500 over the last three years. That fact suggests that there are bargains to be found in the biotech space.

Leave a Reply

Your email address will not be published. Required fields are marked *